Brimapitide Uses, Dosage, Side Effects and more
Brimapitide is under investigation in clinical trial NCT01570205 (Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers).
| Trade Name | Brimapitide |
| Generic | Brimapitide |
| Brimapitide Other Names | Brimapitide |
| Type | |
| Formula | C164H286N66O40 |
| Weight | Average: 3822.514 Monoisotopic: 3820.237428273 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
